|
BioScreening - organic compounds for screening
10.05.2006 Chelsea Therapeutics and Active Biotech to Co-Develop Portfolio of Therapeutics Targeting Autoimmune Disease and Transplant Rejection
Chelsea to Host Conference Call to Discuss New Products and Update
Investors on Clinical Development of Expanded Pipeline
CHARLOTTE, N.C. and LUND, Sweden, May 9, 2006 (PRIMEZONE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) and Active Biotech AB (Stockholm:ACTI), have signed an agreement to co-develop and commercialize the I-3D portfolio of […]
More bioscreening news...
10.05.2006 GEN ID Lab Services, Inc. to Develop New Drug Candidates to Stop Death in Humans from the Avian Flu Virus ('’Bird Flu'’)
GEN ID Lab Services, Inc. (”GEN ID”) (OTC:GDLB) today announced that with the assistance of S2 Biosciences, Inc. (”S2″), a privately held company, it will be developing new drug candidates to treat Bird Flu infections in humans.
Current treatment of H5N1 avian influenza infection includes the use of antiviral therapy such as ribavirin and amantadine and […]
More bioscreening news...
17.05.2006 Elsevier MDL and Key Organics partner to improve chemical sourcing
San Ramon, CA, May 8, 2006 - Elsevier MDL, producer of the MDL® Available Chemicals Directory and MDL® Screening Compounds Directory databases, and Key Organics Ltd., a leading supplier of screening compounds and chemical building blocks, have partnered in an effort to provide improved access to timely, accurate information for chemical sourcing and procurement for […]
More bioscreening news...
17.05.2006 Oxford International’s 7th annual Drug Discovery and Technology Leaders Summit 13th-15th November 2006 Orlando, USA
Oxford International are proud to announce the 7th Annual Drug Discovery and Technology Leaders Summit being held on 13th – 15th November 2006 at the JW Marriott, Grande Lakes, Orlando, USA.
The summit programme will consider how to successfully manage R&D productivity with the aim of shortening time to market through taking a more targeted approach […]
More bioscreening news...
17.05.2006 Oxford International’s Clinical Trial Management Congress 6th-7th November 2006 Philadelphia, USA
Oxford International are pleased to announce the Clinical Trial Management Congress, to be held in Park Hyatt Hotel at the Bellevue, Philadelphia, USA on 6th – 7th November 2006.
The congress offers attendees an unprecedented opportunity to network with leading senior-level clinical trials and technology executives, to identify successful strategies in maximising clinical trial productivity, through […]
More bioscreening news...
new | january 2008 | october 2007 | september 2007 | august 2007 | march 2007 | february 2007 | january 2007 | december 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004 | october 2004 | september 2004 | august 2004 | july 2004 | june 2004 | may 2004 | april 2004 | march 2004 | february 2004 | january 2004 | december 2004 | november 2003 | october 2003 | september 2003 | august 2003 | july 2003 | june 2003 | may 2003
|
